The archive · Health & Care · Strategic decision · 2016–2026
Alan's AI insurer bet: €5B valuation, €785M ARR, first profit after a decade
Alan bet software-native health insurance could win France's mandatory market and then scale to Europe and Canada — €5B valuation, €785M ARR by 2026.
Alan
What the business is
Alan is a French digital health insurer: employers buy its complementary cover for staff, members manage reimbursements, doctor chats and preventive care in a mobile app, and Alan underwrites the risk itself under its own insurance licence.
Starting capital：€173M Series F at a $4.5B valuation in September 2024 led by Belgian bank Belfius (TechCrunch); €100M round at a €5B valuation in March 2026 led by Index Ventures with Greenoaks, Kaaf and SH (TechCrunch).
How it started
Alan was founded in Paris in 2016 by Jean-Charles Samuelian-Werve as the first new independent health insurance company in France in 30 years. Its model treats insurance like software: complementary cover that French employers must buy, a mobile app for reimbursements, doctor chats and preventive care, and a 12–14% management fee over a break-even claims ratio.
What happened
Alan grew from French challenger to European player: more than 500,000 people covered by early 2024, 675,000 across France, Belgium and Spain by October 2024, and €505M revenue in 2024. A €173M Series F led by Belfius at a $4.5B valuation in September 2024 included a distribution deal opening its products to Belfius's corporate clients; it later won a French contract covering up to 135,000 civil servants and took a federal OFSI licence in Canada — the country's first new health insurer in almost 70 years. AI became central: sales results rose about 50% from AI-assisted selling, and 40% of support requests were targeted for full automation by end-2025.
How it ended up
In March 2026 Alan announced €785M ARR for 2025 (+53%), about 1 million members, operational profitability in France and a €5B valuation on a €100M round led by Index Ventures. It is approaching operating break-even — losses halved as a share of revenue — and targets $1.16B ARR in 2026, deliberately prioritising growth over profit.
Background
Alan, founded in Paris in 2016 by Jean-Charles Samuelian-Werve, bet that a software-native insurer could win France's mandatory corporate health market. It launched as the first new independent health insurance company in France in 30 years, with a mobile app for reimbursements, doctor chats and preventive care, and a 12–14% management fee over a break-even claims ratio.
The model scaled through employers and bank partners. By early 2024 Alan covered more than 500,000 people; by October 2024, 675,000 across France, Belgium and Spain. A €173M Series F led by Belgian bank Belfius valued it at $4.5B in September 2024, and a federal licence made it Canada's first new health insurer in almost 70 years, with a plan to onboard one client per week from January 2025.
AI drove the economics. Alan said sales results improved about 50% from AI-assisted selling and planned to fully automate 40% of support requests by end-2025; its team grew only 8% in 2024 while revenue reached €505M (TechCrunch, January 2025). Net losses narrowed from $61M in 2023 to $56M in 2024 and halved as a share of revenue over the following 12 months.
In March 2026 Alan reported €785M ARR for 2025 (+53%), about 1 million members, operational profitability in France and a €5B valuation on a €100M round led by Index Ventures. It is approaching operating break-even and targets $1.16B ARR in 2026, explicitly choosing growth over profit — the payoff of a ten-year bet on licensed, AI-run health insurance.
What has to be true
- A mandated market gave Alan captive demand: every French employer must insure staff, so winning companies with a better app translated directly into members.
- Owning the licence and claims system meant Alan controlled unit economics and UX, rather than buying capacity from incumbents.
- Expansion repeated the play: Belfius distribution in Belgium and a first-new-licence-in-70-years move into Canada targeted markets with weak competition and low satisfaction.
- AI was measured, not rhetorical: about 50% better sales results and automated support let a 740-person company push toward €1B ARR.
- The 2026 trade-off — near break-even, €5B valuation, growth over profit — shows patient capital accepted a long build to a licensed, AI-run insurer.
What can be applied
Regulated markets can be moats: Alan spent nine years as a licensed insurer with software-grade UX and AI cost cuts, and investors backed €5B of scale before profitability arrived.
Aftermath
As of 2026-09-02 Alan is scaling internationally rather than optimising for profit: it reports operational profitability in France, is approaching break-even, and targets $1.16B ARR in 2026. It serves about 1 million members with 740 staff, holds licences in France, Belgium, Spain and all Canadian provinces, and counts HP and Volkswagen among clients. Net losses were $56M in 2024 and halved as a share of revenue over the following year; CEO Samuelian-Werve — also a co-founding adviser at Mistral AI — says Alan's next decade is about becoming a global company, not just a European one.
Sources
- Health insurance startup Alan reaches €5B valuation
- Health insurance startup Alan keeps growing at a rapid pace
- Health insurance startup Alan reaches $4.5B valuation with new $193M funding round
- European unicorn Alan becomes Canada's first new health insurance company in almost 70 years
spotted an error? The archive wants to know.
Your turn
You just read one. Describe what you are building, and see who is betting on the same thing.
Free account · 3 free questions · no card